Segall Bryant & Hamill LLC cut its holdings in Danaher Co. (NYSE:DHR) by 1.8% in the first quarter, HoldingsChannel reports. The institutional investor owned 330,373 shares of the conglomerate’s stock after selling 5,984 shares during the quarter. Segall Bryant & Hamill LLC’s holdings in Danaher were worth $32,347,000 at the end of the most recent reporting period.
Several other institutional investors have also bought and sold shares of the company. Coldstream Capital Management Inc. increased its position in shares of Danaher by 133.0% in the first quarter. Coldstream Capital Management Inc. now owns 9,926 shares of the conglomerate’s stock valued at $972,000 after buying an additional 5,666 shares in the last quarter. WealthPLAN Partners LLC increased its position in shares of Danaher by 28.4% in the first quarter. WealthPLAN Partners LLC now owns 2,893 shares of the conglomerate’s stock valued at $283,000 after buying an additional 640 shares in the last quarter. Verition Fund Management LLC increased its position in shares of Danaher by 72.0% in the first quarter. Verition Fund Management LLC now owns 24,424 shares of the conglomerate’s stock valued at $2,391,000 after buying an additional 10,228 shares in the last quarter. Hilltop Holdings Inc. purchased a new stake in shares of Danaher during the first quarter worth approximately $362,000. Finally, Amundi Pioneer Asset Management Inc. increased its position in shares of Danaher by 149.2% during the first quarter. Amundi Pioneer Asset Management Inc. now owns 1,601,225 shares of the conglomerate’s stock worth $156,775,000 after purchasing an additional 958,663 shares in the last quarter. Institutional investors and hedge funds own 76.61% of the company’s stock.
In other news, CFO Daniel L. Comas sold 78,379 shares of the company’s stock in a transaction on Monday, April 23rd. The stock was sold at an average price of $101.67, for a total value of $7,968,792.93. Following the transaction, the chief financial officer now owns 148,769 shares of the company’s stock, valued at approximately $15,125,344.23. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Thomas Patrick Joyce, Jr. sold 120,354 shares of the company’s stock in a transaction on Friday, April 20th. The shares were sold at an average price of $101.17, for a total value of $12,176,214.18. Following the completion of the transaction, the insider now directly owns 151,959 shares in the company, valued at approximately $15,373,692.03. The disclosure for this sale can be found here. In the last ninety days, insiders sold 241,940 shares of company stock worth $24,527,925. Corporate insiders own 11.90% of the company’s stock.
Several analysts recently commented on DHR shares. Robert W. Baird reiterated a “buy” rating and set a $106.00 price target on shares of Danaher in a research report on Friday, April 20th. Zacks Investment Research upgraded Danaher from a “hold” rating to a “buy” rating and set a $113.00 price target for the company in a research report on Thursday, May 17th. Credit Suisse Group reiterated an “outperform” rating on shares of Danaher in a research report on Friday, March 9th. Stifel Nicolaus reiterated a “buy” rating and set a $114.00 price target (up from $108.00) on shares of Danaher in a research report on Thursday, April 19th. Finally, Morgan Stanley boosted their price target on Danaher from $112.00 to $113.00 and gave the stock an “overweight” rating in a research report on Friday, April 20th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and fourteen have assigned a buy rating to the stock. Danaher presently has a consensus rating of “Buy” and a consensus price target of $105.69.
NYSE DHR traded up $0.07 on Thursday, reaching $102.69. 15,717 shares of the company were exchanged, compared to its average volume of 2,384,940. The firm has a market capitalization of $72.12 billion, a P/E ratio of 25.52, a price-to-earnings-growth ratio of 1.94 and a beta of 1.03. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.15 and a current ratio of 1.59. Danaher Co. has a fifty-two week low of $78.97 and a fifty-two week high of $104.82.
Danaher (NYSE:DHR) last released its quarterly earnings data on Thursday, April 19th. The conglomerate reported $0.99 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.94 by $0.05. The company had revenue of $4.70 billion for the quarter, compared to analyst estimates of $4.54 billion. Danaher had a return on equity of 11.39% and a net margin of 13.56%. The firm’s revenue for the quarter was up 11.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.85 earnings per share. sell-side analysts forecast that Danaher Co. will post 4.45 EPS for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, July 27th. Stockholders of record on Friday, June 29th will be paid a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 0.62%. The ex-dividend date of this dividend is Thursday, June 28th. Danaher’s dividend payout ratio (DPR) is presently 15.88%.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.